tiprankstipranks
Trending News
More News >
Edwards Lifesciences (EW)
NYSE:EW
US Market

Edwards Lifesciences (EW) Income Statement

Compare
1,919 Followers

Edwards Lifesciences Income Statement

Last quarter (Q3 2025), Edwards Lifesciences's total revenue was $1.55B, an increase of 14.67% from the same quarter last year. In Q3, Edwards Lifesciences's net income was $291.10M. See Edwards Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.44B$ 5.01B$ 5.38B$ 5.23B$ 4.39B
Gross Profit
$ 4.32B$ 3.97B$ 4.22B$ 4.01B$ 3.29B
Operating Expenses
$ 2.94B$ 2.55B$ 2.51B$ 2.40B$ 1.99B
Depreciation and Amortization
$ 155.20M$ 144.90M$ 166.80M$ 163.30M$ 135.40M
EBITDA
$ 1.72B$ 1.53B$ 1.96B$ 1.89B$ 1.07B
Operating Income
$ 1.38B$ 1.43B$ 1.70B$ 1.61B$ 1.30B
Other Income/Expenses
$ 169.40M$ -54.90M$ 65.00M$ 91.60M$ -379.30M
Pretax Income
$ 1.55B$ 1.37B$ 1.77B$ 1.70B$ 916.70M
Net Income
$ 4.17B$ 1.40B$ 1.52B$ 1.50B$ 823.40M
Per Share Metrics
Basic EPS
$ 6.98$ 2.31$ 2.46$ 2.41$ 1.32
Diluted EPS
$ 6.97$ 2.30$ 2.44$ 2.38$ 1.30
Weighted Average Shares Outstanding
597.70M 606.70M 619.00M 623.30M 622.60M
Weighted Average Shares Outstanding (Diluted)
599.30M 609.40M 624.20M 631.20M 631.90M
Currency in USD

Edwards Lifesciences Earnings and Revenue History